Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Ozempic can lead to sulfur burps because its slowed gastric emptying and altered gut flora increase hydrogen sulfide production, a symptom many users report during dose escalation.
Most cases are manageable with diet changes, hydration, and probiotics, but persistent or severe symptoms may require dose adjustment or switching to another medication. There are several factors to consider, so see below for complete details on when and how to adjust your therapy.
Sulfur burps—those foul-smelling belches that resemble rotten eggs—can be an unwelcome side effect of taking Ozempic (semaglutide). If you've ever wondered why does Ozempic cause sulfur burps, you're not alone. Understanding the science behind this symptom, practical ways to manage it, and when to consider switching medications can help you make informed decisions about your treatment.
Sulfur burps occur when hydrogen sulfide gas (H₂S) is produced in the gastrointestinal (GI) tract and expelled through belching. Common triggers include:
While occasional sulfur burps are typically harmless, persistent or severe episodes can impact quality of life and may signal another digestive issue.
Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for type 2 diabetes and weight management. It mimics the natural hormone GLP-1 to:
The slowed gastric emptying and altered gut motility are key reasons why Ozempic causes sulfur burps:
Delayed Gastric Emptying
Food remains in the stomach longer, providing more time for bacteria to ferment proteins and release sulfur compounds.
Changes in Gut Flora
Altered gut transit time can shift the balance of gut bacteria, sometimes promoting overgrowth of sulfur-producing species.
Increased Protein Fermentation
Higher protein breakdown in the upper GI tract generates more hydrogen sulfide gas.
Clinical trials of semaglutide list GI side effects such as nausea, diarrhea, and abdominal discomfort. While sulfur burps are not always singled out in large studies, many patients report them anecdotally:
If you experience sulfur burps, track frequency and severity to discuss with your healthcare provider.
Most sulfur burps are more annoying than harmful. However, consult a doctor if you experience any of the following:
If you're unsure whether your symptoms require medical attention, try Ubie's free Medically approved LLM Symptom Checker Chat Bot to get personalized guidance on your next steps.
Before considering a medication change, try these practical tips:
• Dietary Adjustments
• Slow Down and Chew Well
• Hydration
• Probiotics and Digestive Enzymes
• Activated Charcoal
If sulfur burps persist despite lifestyle changes, you and your doctor might weigh the pros and cons of continuing Ozempic versus trying another option:
Dose Adjustment
Alternative GLP-1 Agonists
Switching Drug Classes
Combination Therapy
Always discuss any medication changes with your healthcare provider to ensure you continue to meet your treatment goals safely.
Always reach out for urgent care if you experience:
These could signal complications needing prompt evaluation.
By understanding the mechanisms and taking proactive steps, you can reduce discomfort without compromising your treatment goals. If in doubt, your physician is the best resource to tailor therapy to your needs.
(References)
* Wang, X., Song, Y., Han, H., Ding, Y., Sun, X., Su, W., ... & Li, C. (2024). Gastrointestinal adverse events of GLP-1 receptor agonists for the treatment of type 2 diabetes and obesity: A systematic review and network meta-analysis. *Diabetes, Obesity and Metabolism*, *26*(2), 490-503.
* O'Brien, P., Davies, M. J., & Semaglutide Systematic Review and Meta-analysis Group. (2023). Semaglutide in type 2 diabetes and obesity management: a systematic review and meta-analysis. *BMJ*, *382*, e074360.
* Nauck, M. A., Meier, J. J., & Nauck, M. A. (2020). Management of Gastrointestinal Adverse Events with Glucagon-Like Peptide-1 Receptor Agonists: A Clinical Approach. *Drugs*, *80*(1), 1-12.
* Yan, F., Chen, S., Li, Y., Liang, J., & Guo, Q. (2023). Glucagon-Like Peptide-1 Receptor Agonists and Gut Microbiota: Implications for Obesity and Type 2 Diabetes. *Nutrients*, *15*(3), 658.
* Mikhail, N., & Elshafei, A. (2023). Patient-Reported Outcomes and Health-Related Quality of Life With Semaglutide: A Systematic Review. *Diabetes Therapy*, *14*(4), 507-526.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.